Answers are grounded in this paper and cite their sources.
Two patients recieving intravenous high dose methotrexate (MTX) and intracutaneous BCG injections as adjuvant treatment for osteogenic sarcoma suffered sudden cardiovascular collapse within minutes of infusion of MTX. These cases demonstrate that anaphylactic or idiosyncratic reactions to MTX and/or contaminants in these preparations do occur and that careful patient monitoring is required.
No takes yet. Share an insight, caveat, or question.
Goldberg et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: